SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-014119
Filing Date
2023-04-24
Accepted
2023-04-24 16:39:25
Documents
13
Period of Report
2023-03-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A crbp-20230303.htm   iXBRL 8-K/A 63257
2 EX-10.1 crbp-ex10_1.htm EX-10 89225
  Complete submission text file 0000950170-23-014119.txt   289786

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230303.xsd EX-101.SCH 2474
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230303_lab.xml EX-101.LAB 13992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230303_pre.xml EX-101.PRE 11485
7 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230303_htm.xml XML 5373
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37348 | Film No.: 23840594
SIC: 2834 Pharmaceutical Preparations